Editor
The most recent financial statement from telehealth company Amwell isn’t pretty.
Amwell posted an annual net loss of $272.1 million, or $0.99 per share. In its 2022 annual report, the company said expects to pay higher costs this year to scale its business and increase revenue. The company said it may have to raise additional capital through debt or equity financing
At the ViVE digital health industry conference last week, CEO Roy…
